Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|January 9, 2014
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Journal of Cutaneous Pathology|November 22, 2012
Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumorSima Rozati, Katrin Kerl, Werner Kempf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCLSima Rozati, Phil F Cheng, Daniel S Widmer, et al.
Immunotherapy|February 19, 2013
Melanoma immunotherapy: historical precedents, recent successes and future prospectsMarieke I G Raaijmakers, Sima Rozati, Simone M Goldinger, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 20, 2023
Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sézary Syndrome Compared to a Matched Control CohortCourtney M Johnson, Sai M Talluru, Bianka Bubic, et al.
Plos One|March 22, 2013
RASopathic skin eruptions during vemurafenib therapyJeannine D Rinderknecht, Simone M Goldinger, Sima Rozati, et al.
British Journal of Haematology|March 24, 2025
The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphomaOlivia Pierog, Taylor Craig, Jacky Jennings, et al.
Acta Dermato-Venereologica|September 23, 2020
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical DataIris Amitay-Laish, Emmanuella Guenova, Pablo L Ortiz-Romero, et al.
Journal of the American Academy of Dermatology|March 18, 2026
Health disparities in narrowband UVB phototherapy for mycosis fungoides: A multi-institutional cohort study across Fitzpatrick skin typesCaroline Chen, Maggie H Zhou, Yoni Sacknovitz, et al.
Plos One|October 2, 2015
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?Joanna Mangana, Phil F Cheng, Katja Schindler, et al.
Pageof 3